...
首页> 外文期刊>Journal of Medicinal Chemistry >An Unusual Natural Product Primary Sulfonamide: Synthesis, Carbonic Anhydrase Inhibition, and Protein X-ray Structures of Psammaplin C
【24h】

An Unusual Natural Product Primary Sulfonamide: Synthesis, Carbonic Anhydrase Inhibition, and Protein X-ray Structures of Psammaplin C

机译:一种不寻常的天然产物伯磺酰胺:合成,碳酸酐酶抑制和Psammaplin C的蛋白质X射线结构。

获取原文
获取原文并翻译 | 示例

摘要

Psammaplin C is one of only two described natural product primary sulfonamides. Here we report the synthesis of psammaplin C and evaluate the inhibition profile against therapeutically relevant carbonic anhydrase (CA) zinc metalloenzymes. The compound exhibited unprecedented inhibition of an important cancer-associated isozyme, hCA XII, with a K-i of 0.79 nM. The compound also displayed good isoform selectivity for hCA XII over other CAs. We present the first reported protein X-ray crystal structures of psammaplin C in complex with human CAs. We engineered the easily crystallized hCA II enzyme to mimic both the hCA IX and hCA XII binding sites and then utilized protein X-ray crystallography to determine the binding pose of psammaplin C within the hCA II, hCA IX, and hCA XII mimic active sites, all to high resolution. This is the first time a natural product primary sulfonamide inhibitor has been assessed for inhibition and binding to CAs.
机译:帕马普林C是仅两种描述的天然产物伯磺酰胺之一。在这里,我们报告了psammaplin C的合成,并评估了对治疗相关的碳酸酐酶(CA)锌金属酶的抑制作用。该化合物对重要的癌症相关同功酶hCA XII表现出前所未有的抑制作用,K-i为0.79 nM。该化合物对hCA XII的选择性也优于其他CA。我们目前首次报道与人CA复杂的psammaplin C的蛋白质X射线晶体结构。我们设计了易于结晶的hCA II酶以模拟hCA IX和hCA XII结合位点,然后利用蛋白质X射线晶体学确定psammaplin C在hCA II,hCA IX和hCA XII模拟活性位点内的结合姿势,全部到高分辨率。这是首次评估天然产物伯磺酰胺抑制剂的抑制作用以及与CA的结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号